Forget WELL Health (TSX:WELL) Stock: This Stock Pays Better

If Motley Fool Canada investors are interested in WELL Health (TSX:WELL) stock, they’ll definitely want to check out this healthcare stock with far more returns.

| More on:
healthcare pharma

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

WELL Health Technologies (TSX:WELL) has been one of the top growth stocks on the TSX during the pandemic. But even as the pandemic comes to a close, WELL Health stock continues to trend higher and higher.

The $1.61 billion Canadian telehealth company has become a superstar during the last year, all thanks to the massive shift into telehealth. The pandemic meant patients that needed healthcare could no longer see their physicians and other healthcare professionals in person. Telehealth companies like WELL Health stock provided a means to do this.

But it didn’t stop there. WELL Health stock and others became a tool for almost every type of healthcare company. Whether it’s physiotherapy or dermatology you’re seeking, you can usually have at least an initial appointment online. This saves time, money, and, most importantly, lives. It looks like telehealth is here to stay.

Why not WELL Health stock?

I’m giving Motley Fool Canada investors a lot of reasons to buy WELL Health stock, and I’m not saying it’s a bad purchase. Shares of the company are up 5,500% since coming on the market and 203% in the last year alone. WELL Health stock management recently reported record-setting revenue during the latest earnings report, with 150% year-over-year growth.

On top of that, the company has continued its growth-through-acquisition strategy. Most recently, that’s included a massive move into the United States. The company is now on the verge of becoming a global operation. That’s all good news!

The bad news? It’s the price. Sure, WELL Health stock still looks cheap with a $8.65 share price as of writing. But the growth it’s seeing now is bound to start slowing down. But the stock is moving quickly towards overbought territory with a Relative Strength Index (RSI) of 69 (70 is overbought). Meanwhile, its price-to-earnings (P/E) ratio is predicted to be 110.8 for the next 12 months — an insanely high amount.

But Motley Fool Canada investors can get similar growth and guaranteed income from the growing healthcare industry without investing in WELL Health stock. Instead, consider NorthWest Healthcare Properties REIT (TSX:NWH.UN).

Stable healthcare growth

NorthWest Healthcare is a strong option for those seeking both growth and guaranteed income. The company is a real estate investment trust (REIT), so 90% of taxable income must be paid out to shareholders, and this usually comes out as dividends. But on top of that, it’s in the growing healthcare sector. It’s one of the few REITs that actually saw revenue increase during the pandemic, as it was a necessary service. So, that means it was able to keep that dividend steady and stable.

Beyond that, with rents coming in the company was also able to expand. Most recently, NorthWest has been expanding in a similar way to WELL Health stock, acquiring more and more businesses. That includes a $200 million acquisition in the Netherlands and a whopping A$2.6 billion acquisition in Australia.

Revenue continued to climb for this company, even before it started acquiring businesses. Most recently, NorthWest reported 98.5% international occupancy, with an average lease agreement of 14.3 years! Total assets under management increased by 16.2% year over year as well to $7.7 billion.

It gets better…

The best part? The stock is actually cheap, both in share price and in fundamentals. Shares currently trade at $12.75, up 29% in the last year and 130% since coming on the market. And its P/E ratio is an insanely cheap 9.52 as of writing, with an RSI fairly valued at 46. And whereas WELL Health stock could slow down soon, analysts predict a potential upside of 14% in the next year.

Add on top of that something WELL Health stock doesn’t have: a dividend yield. Motley Fool Canada investors can currently pick up NorthWest and lock in a dividend yield of 6.19% as of writing. That’s guaranteed income of, say, $1,882 each year from a $30,000 investment.

For me, it’s a no brainer. Sure, WELL Health stock has grown, but that growth will slow eventually. NorthWest, however, will keeping paying far beyond that time.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe owns shares of NORTHWEST HEALTHCARE PPTYS REIT UNITS and WELL Health Technologies Corp. The Motley Fool recommends NORTHWEST HEALTHCARE PPTYS REIT UNITS.

More on Coronavirus

Business success with growing, rising charts and businessman in background
Coronavirus

1 Growth Stock Every Canadian Investor Should Consider Right Now

This growth stock saw shares pop 10% on June 20, as one analyst stated there is a significant opportunity to…

Read more »

Aircraft wing plane
Coronavirus

Bombardier Stock Merge: What it Means for Investors

Bombardier (TSX:BBD.B) stock went through a reverse stock split on June 13, turning 25 shares into one in one swift…

Read more »

Aircraft wing plane
Coronavirus

Air Canada (TSX:AC) Stock: Ready to Take Off?

While Air Canada is handling what it can control really well, there are many worsening macro headwinds that will likely…

Read more »

rail train
Coronavirus

Bull or Bear: Why Analysts Changed Their Tune on Aecon Stock

Analysts had been champing at the bit for the construction company, but the tides have turned.

Read more »

Biotech stocks
Coronavirus

Is Bellus Health Stock Still a Buy After 30% Earnings Jump?

The biotech continues to make progress on obtaining FDA approval for its chronic-cough therapy.

Read more »

grow dividends
Coronavirus

Goodfood Stock Likely to Double in 2022!

Goodfood (TSX:FOOD) stock has had a huge rise and fall in the last few years. But at $1.85 a share,…

Read more »

grow dividends
Coronavirus

Canfor Stock Pops 5% as Sales Climb 15% YOY

Canfor (TSX:CFP) stock remained positive about its future in the global lumber market after profits climb 15% year over year.

Read more »

edit Safety First illustration
Coronavirus

2 Crash-Proof TSX Stocks I’d Buy With $5,000

These two TSX stocks have proven they can handle this economic downturn and likely will continue to be safe far…

Read more »